Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares TIPS Bond ETF (TIP) vs Veeva Systems (VEEV) Price & Performance

iShares TIPS Bond ETFTrade
Veeva SystemsTrade

Price performance (Past 24H)

Key statistics

iShares TIPS Bond ETF vs Veeva Systems — how do they compare? iShares TIPS Bond ETF trades at $106.82, while Veeva Systems trades at $260.88 (market cap $42.88B). The key difference: Veeva Systems is trading nearer its 52-week high, iShares TIPS Bond ETF nearer its low. Which is the better fit depends on your goals.

TIPVEEV
Sector
Fixed IncomeTechnology
52-Week High
$112.20$306.22
52-Week Low
$106.77$151.43
Market Cap
$42.88B
Enterprise Value
$35.79B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares TIPS Bond ETF

TIP trades at $107.05 with minimal daily movement (+0.07%), showing stability amid broader market volatility. Technical indicators signal a bearish trend with moving averages and overall momentum favoring sellers. The company has announced upcoming dividends totaling $1.84 per share for H2-2026, providing income appeal. Recent news highlights Treasury market volatility and inflation concerns that may impact bond-related equities.

The stock faces headwinds from bearish technical momentum and macroeconomic uncertainty around interest rates. Dividend payments offer some support, but limited fundamental data availability requires careful monitoring of upcoming financial disclosures for clearer valuation assessment.

Veeva Systems

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

About iShares TIPS Bond ETF

TIP is the flagship ETF for U.S. Treasury Inflation-Protected Securities (TIPS). It tracks an index of government bonds whose principal value adjusts based on the Consumer Price Index (CPI), providing a direct hedge against rising inflation.

Read more on TIP

About Veeva Systems

Veeva Systems provides cloud software, data, and services for the life sciences industry. Its applications support functions across clinical research, regulatory operations, quality, safety, and commercial teams.

Read more on VEEV